On this week’s BioTech Nation, the focus is Alzheimer’s Disease. Dr. Gunn speaks with Kevin Cox, CEO of Imanova about the ability to actually examine the state of the brain on a more routine basis, improving diagnosis and predicting the success or failure of drugs. Then, it’s Dr. Charles Stacey, the President and CEO of Accera. The basis for their Alzheimer’s treatment centers on glucose uptake in the brain.
On this week’s BioTech Nation, Andreas Weigand, former chief scientist at Amazon, and author of “Data for the People.” Then on Tech Nation Health, Dr. Marshall Summar, Director of the Rare Disease Institute and Chief of Genetics and Metabolism at Children’s National Health System in Washington, DC. They talk about treating rare diseases in the very young, and the efforts to support families, local pediatricians and the patients themselves, nationwide and around the world.
On this week’s BioTech Nation, a full hour of Tech Nation Health, reimagining the future of health and healthcare with the emergence of new technologies. DR. DANIEL KRAFT, Chief Correspondent for Tech Nation Health talks about the future of Surgery and Other Interventions. Purdue Professor, DR. PHIL LOW, the Director of Purdue Center for Drug Discovery and Chief Scientific Officer of Endocyte, talks about why it’s hard to surgically remove all the cancerous tissue, and a technology that can change that. And DR. RICHARD KUHN, the Director of the Purdue Institute for Inflammation, Immunology and Infectious Disease. He was the first to discover the structure of the Zika virus, and he compares it to other viruses, like Polio and HIV.
On this week’s BioTech Nation, in the pediatric area, diagnosing some behavioral problems and mental disorders by testing the immune system. Dr. Craig Shimasaki, the CEO of Moleculera Labs, explains their test and the science behind it.
On this week’s BioTech Nation, correcting the underrepresentation of Latinos in testing pharmaceuticals and directly addressing the Zika virus in humans. Dr. Kosmas Kretsos, the Executive Director of the Puerto Rico Consortium for Clinical Investigation (PRCCI) describes the efforts underway in Puerto Rico.
On this week’s BioTech Nation, a new approach to achieving health with a compromised immune system. Dr. DAVID JOHNSON is the Founder, President & CEO of GigaGen. And critically-ill newborns get the genetic information they need … and fast. GAVIN STONE is the Vice President for Marketing at EdicoGenome in San Diego.
On this week’s Bio Tech Nation, neuroscientist Daniel Levitin talks about how we can tell the difference between a simple lie and a weaponized lie. His book is “Weaponized Lies: How to Think Critically in the Post-Truth Era.” Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft tells us about The Internet of Medical Things. And what it can do for us.
On BioTech Nation with Dr Moira Gunn, upping the game for wearables – NOAH KONIG from Cambridge Cognition and BEN FEHNERT from The CTRL Group, talk about their new venture, Cognition Kit. Measuring cognition along with the impact of medications, and opening up these measurements for others to develop applications.
On this week’s BioTech Nation, “The NPR Math Guy”, Keith Devlin, tells us about Finding Fibonacci: The Quest to Rediscover the Forgotten Mathematical Genius Who Changed the World”. Then on Tech Nation Health, chief correspondent Dr. Daniel Kraft tells us about the winners of the Qualcomm Tricoder Xprize - StarTrek medicine isn’t fiction any more.
On this week’s BioTech Nation, Brad Stone from Bloomberg News talks about “The Upstarts: How Uber, Airbnb, and the Killer Companies of the New Silicon Valley Are Changing the World.” And on Tech Nation Health, integrating the data from all our smartphones apps and exercise bands, and much more. Drew Schiller is the CEO of Validic. And remember that every nation approves drugs, medical devices and even cosmetics differently. Greer Deal, the Director of Global Regulatory Services, breaks it down.